Medical network on April 7 - April 6, the CFDA website "about 5 batch drug unqualified notice no. 53 (2017), according to the four drug inspection institutions such as jilin pharmaceutical inspection examines, labeled JiLinJi state pharmaceutical co., LTD. Four companies such as the production of 5 batch unqualified drugs. 

 

Unqualified product labeling production enterprises, drug name and batch number is: tianjin da Wan Gong RenTang Beijing pharmaceutical co., LTD., production batch number for 408513 of rheumatism fluid, JiLinJi state pharmaceutical co., LTD., production batch number is 20160301, and 20160302 female bao capsule, linjiang city grand pharmaceutical co., LTD., production batch number of 160202 pu blue tablet, kang county alone blindly biological pharmaceutical co., LTD., production batch number for 1601273001 pieces of ginseng and astragalus fructus schisandrae. The unqualified project has the content determination, microbial limit, the weight difference. 

 

5 batch unqualified drugs list 

For the unqualified drugs, the relevant provinces, autonomous regions and municipalities directly under the food and drug administration has taken seized seized control measures, such as requiring companies to suspend sales use, recalls, and rectification. 

 

CFDA request production enterprises home provinces (autonomous regions and municipalities) food and drug administration of the enterprise on the basis of the pharmaceutical administration law of the People's Republic of China article seventy-four, seventy-four, seventy-five regulations, such as the production and sales of unqualified drugs illegal behavior to carry on the investigation, three months for production and sales of unqualified drugs public enterprises or units deal, and administration of relevant situation report in time.